![]() |
Volumn 91, Issue 3, 2002, Pages 233-237
|
Pilot study for the use of dose-reduced alteplase and the glycoprotein IIb/IIIa inhibitor tirofiban in acute myocardial infarction;Pilotstudie zur wirksamkeit einer kombinationstherapie einer reduzierten dosis von alteplase und dem glykoprotein IIb/IIIa antagonisten tirofiban beim akuten myokardinfarkt
|
Author keywords
Fibrinolysis; Glycoprotein IIb IIIa inhibitor; Stent implantation; TIMI flow
|
Indexed keywords
ALTEPLASE;
FIBRINOGEN RECEPTOR ANTAGONIST;
TIROFIBAN;
ACUTE HEART INFARCTION;
ADULT;
AGED;
ANGIOCARDIOGRAPHY;
ARTICLE;
BLEEDING;
BOLUS INJECTION;
CLINICAL ARTICLE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MIXTURE;
FEMALE;
HUMAN;
MALE;
PILOT STUDY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
COMBINED MODALITY THERAPY;
CORONARY ANGIOGRAPHY;
CORONARY CIRCULATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
FIBRINOLYTIC AGENTS;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE);
PILOT PROJECTS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
STENTS;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
TYROSINE;
|
EID: 0036131187
PISSN: 03005860
EISSN: None
Source Type: Journal
DOI: 10.1007/s003920200016 Document Type: Article |
Times cited : (4)
|
References (13)
|